Lifetime risk for breast and ovarian cancer in postmenopausal BRCA carriers: cause for concern?

被引：0
|
作者：
Tice, J. A. [1 ]
Crawford, B. [1 ]
Ziegler, J. [1 ]
McLennan, J. [1 ]
Beattie, M. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [41] Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers
    Vicus, Danielle
    Rosen, Barry
    Lubinski, Jan
    Domchek, Susan
    Kauff, Noah D.
    Lynch, Henry T.
    Isaacs, Claudine
    Tung, Nadine
    Sun, Ping
    Narod, Steven A.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 115 (01) : 135 - 137
  • [42] Oophorectomy reduces risk of ovarian cancer in BRCA mutation carriers by 80%
    [J]. Nature Clinical Practice Oncology, 2006, 3 (10): : 526 - 527
  • [43] The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers Implications for Counseling
    Vencken, Peggy M. L. H.
    Kriege, Mieke
    Hooning, Maartje
    Menke-Pluymers, Marian B.
    Heemskerk-Gerritsen, Bernadette A. M.
    van Doorn, Lena C.
    Collee, Margriet M.
    Jager, Agnes
    van Montfort, Cees
    Burger, Curt W.
    Seynaeve, Caroline
    [J]. CANCER, 2013, 119 (05) : 955 - 962
  • [44] Effect of Breast Cancer After Ovarian Cancer on Mortality for BRCA Mutation Carriers Reply
    Gangi, Alexandra
    Baramparas, Galinos
    Amersi, Farin F.
    [J]. JAMA SURGERY, 2015, 150 (05) : 491 - 492
  • [45] Breast cancer incidence in BRCA mutation carriers with ovarian cancer: A longitudal observational study
    Safra, Tamar
    Waissengrin, Barliz
    Gerber, Deanna
    Bernstein-Molho, Rinat
    Klorin, Geula
    Salman, Lina
    Josephy, Dana
    Chen-Shtoyerman, Rakefet
    Bruchim, Ilan
    Frey, Melissa K.
    Pothuri, Bhavana
    Muggia, Franco
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 162 (03) : 715 - 719
  • [46] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Leendert H Zaaijer
    Helena C van Doorn
    Marian J E Mourits
    Marc van Beurden
    Joanne A de Hullu
    Muriel A Adank
    Luc R C W van Lonkhuijzen
    Hans F A Vasen
    Brigitte F M Slangen
    Katja N Gaarenstroom
    Ronald P Zweemer
    Peggy M L H Vencken
    Caroline Seynaeve
    Mieke Kriege
    [J]. British Journal of Cancer, 2016, 115 : 1174 - 1178
  • [47] Risk of primary and contralateral breast cancer in BRCA1/2 mutation carriers previously affected with ovarian cancer
    Heemskerk-Gerritsen, B. A. M.
    Hooning, M. J.
    van Doorn, H. C.
    Collee, M.
    Koppert, L. B.
    Jager, A.
    van den Ouweland, A. M. W.
    Seynaeve, C.
    Kriege, M.
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 528 - 528
  • [48] Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
    Zaaijer, Leendert H.
    van Doorn, Helena C.
    Mourits, Marian J. E.
    van Beurden, Marc
    de Hullu, Joanne A.
    Adank, Muriel A.
    van Lonkhuijzen, Luc R. C. W.
    Vasen, Hans F. A.
    Slangen, Brigitte F. M.
    Gaarenstroom, Katja N.
    Zweemer, Ronald P.
    Vencken, Peggy M. L. H.
    Seynaeve, Caroline
    Kriege, Mieke
    [J]. BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1174 - 1178
  • [49] Risk of primary and contralateral breast cancer in BRCA1/2 mutation carriers previously affected with ovarian cancer
    Heemskerk-Gerritsen, B. A. M.
    Hooning, M. J.
    van Doorn, H. C.
    Collee, M. J.
    Koppert, L. B.
    Jager, A.
    van den Ouweland, A. M. W.
    Netherlands, H.
    Seynaeve, C.
    Kriege, M.
    [J]. CANCER RESEARCH, 2017, 77
  • [50] BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers
    Sun, Jie
    Chu, Futao
    Pan, Jiani
    Zhang, Yaxin
    Yao, Lu
    Chen, Jiuan
    Hu, Li
    Zhang, Juan
    Xu, Ye
    Wang, Xiaojia
    Cao, Wenming
    Xie, Yuntao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (05) : 991 - +
12345